MKI67 and neoplasm: Consistent with the in vitro proliferation assay, the tumors from the shSLC25A19 group contained fewer Ki‐67‐positive cells than those from the shCtrl group (Figure 5D), confirming that SLC25A19 may contribute to tumor proliferation in vivo.